Net loss per share (Tables)

12 Months Ended

Dec. 31, 2025

Earnings Per Share [Abstract]

Schedule of antidilutive securities excluded from computation of earnings per share

The Company excluded the following potential common shares presented based on amounts outstanding at period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:

	Years Ended December 31,
	2025	2024
Class A Warrants	50,608,500	—
Class B Warrants	50,608,500	—
Options to purchase common stock	13,703,967	11,849,611
Restricted Stock Units	2,818,751	1,443,319
	117,739,718	13,292,930

Schedule of basic and diluted loss per share

Potential Common Stock consists of the incremental Common Stock issuable upon the exercise of stock options and warrants (in thousands, except share and per share data):

	Years Ended December 31,
	2025		2024
Numerator:
Net loss —basic and diluted	$	(104,994)	$	(105,316)
Denominator:
Weighted-average common stock outstanding	76,915,757		69,372,993
Weighted average of pre-funded warrants exercisable for nominal consideration	5,978,702		—
Weighted-average number of shares—basic and diluted	82,894,459		69,372,993
Net loss per share —basic and diluted	$	(1.27)	$	(1.52)